Menu

Top Stories

Published on Wednesday, April 20, 2016

Kevin Shroyer, father of Alpha lung donor, completes Boston Marathon

Kevin Shroyer, father of Alpha lung donor, completes Boston Marathon

Kevin Shroyer, the father of a 14-year-old girl whose donated lungs saved an Alpha’s life, completed the Boston Marathon on Monday, April 18 in her honor.

Kevin Shroyer

Although the experienced distance runner was happy to cross the finish line, he said he would like to post a faster time next year. He qualified for the event by completing a previous marathon in three hours and 35 minutes, but finished on Monday in 4:01.

"Since it was not what I was expecting to run, I will let everyone know what happened,” he wrote Monday on his Facebook page. “I was pretty much right on my pace upon climbing the infamous Heartbreak Hill. However, upon descending the back side, my right quad seized up suddenly, forcing me to come to a dead stop and grab onto a handrail to keep from falling.

“Fortunately, I was running close to the side of the road at the time. A sweet older woman spectator immediately saw the distress I was in as I could not straighten that leg out below the knee. She held onto me until the pain subsided and I was able to gradually massage it until it released, but my day was effectively over at that point.”

Calling it a “frustrating and humbling” experience, Shroyer struggled over the last six miles, alternating between fast walking and very slow running.

“This was something that had NEVER happened to me before in a race,” he wrote. “However, I accomplished goal #1 and that was to qualify, run, and finish the race for Korinne and to promote organ, tissue and eye donation on the biggest running stage in the world! It wasn't my plan to be out there for 4:01, but perhaps it was God's plan.

“Timewise, this was my worst marathon in years. But, maybe by me being out there all those additional minutes, someone was impacted by seeing Korinne's picture on the back of my singlet and the fact that she was an organ and tissue donor. Indeed, I had a number of other runners, male and female, offer expressions of condolence to me throughout the day, which was nice. So, if that is the one positive takeaway from today's experience, then I can accept that and would do it all over again!”

Shroyer has already qualified for the 2017 Boston Marathon, and he plans to run it.

“After looking at today's result they might not want me back, but too bad, I am coming!” he said. “Today will not be my defining Boston moment!"

To read about how Shroyer prepared for the Boston Marathon, click here.


Print

Arrowhead completes enrollment in Phase 1 study for treatment of Alpha-1 liver disease

Tuesday, June 19, 2018
Arrowhead Pharmaceuticals, Inc. announced that it has completed enrollment of a Phase 1 clinical trial of ARO-AAT, their second generation subcutaneously administered RNA interference (RNAi) therapeutic that is being developed as a treatment for...
Divider

Alphas will hold one of their biggest meetings in San Francisco

Monday, June 18, 2018
The city of San Francisco, California, will be the site of one of the biggest gatherings of Alphas, when the Alpha-1 Foundation holds, between June 29 – July 1, 2018, its 27th Annual National Education Conference. Alphas – as those...
Divider

New foundation will increase awareness about cell and gene therapy, but caution is recommended

Thursday, June 7, 2018
The Alliance for Regenerative Medicine (ARM) announced the launch of the ARM Foundation for Cell and Gene Medicine, which will be dedicated to increasing public awareness and understanding of the clinical and societal benefits of cell and gene...
Divider

NORD opposes implementation of copay accumulator programs in health plans

Tuesday, June 5, 2018
The National Organization for Rare Disorders (NORD), the nonprofit institution that represents 30 million Americans that suffer from rare diseases, issued the following statement on the increasing use of copay accumulator programs in health...
Divider

RNA interference therapies could be on the verge of success

Tuesday, May 29, 2018
In the mid-2000s there was a wave of excitement across the pharmaceutical industry: a new discovery about cells that had the potential to transform medicine.  “The world became enamored with this idea because it was very powerful. If...
Divider

Consortium seeks common standards for gene-editing therapies

Thursday, May 24, 2018
How to best measure if a therapy is reaching its target gene without introducing errors in others? This is one of the big questions that remain unanswered, as the first CRISPR clinical trials begin in the U.S. and Europe, in 2018. To address...
Divider

2018 research grants on Alpha-1 awarded

Tuesday, May 22, 2018
At a cocktail reception the evening of May 21st, held at The Prado at Balboa Park, within the framework of the American Thoracic Society (ATS) 2018 International Conference in San Diego, California, the Alpha-1 Foundation (A1F) announced the...
Divider

Mark Brantly honored with John W. Walsh PAR Award for Excellence

Monday, May 21, 2018
The Alpha-1 Foundation (A1F) extends a heartfelt message of congratulations to Alpha-1 Antitrypsin Deficiency (Alpha-1) researcher and pioneer, Mark Brantly, MD, for being the first recipient of the newly renamed 2018 John W. Walsh PAR Award for...
Divider

Donohue to receive the Breathing for Life Award

Friday, May 18, 2018
James F. Donohue, MD, will be honored with the Breathing for Life Award at the Tenth Annual American Thoracic Society (ATS) Foundation Research Program Benefit on Saturday, May 19th, 2018, in San Diego, California. The Award is the highest honor...
Divider

Alpha Jonathan Maidment hikes the Pacific Crest Trail

Thursday, May 17, 2018
This story appears in the Spring 2018 issue of Alpha-1-To-One Magazine. Subscriptions are free. Determined and driven are the first two adjectives that come to mind when you get a grasp of the endeavor that 23-year old Jonathan Maidment has...
Divider

Spring has built new friends to find a cure

Thursday, May 17, 2018
The Building Friends for a Cure (BFC) program was created by the Alpha-1 Foundation (A1F) to make new friends and nurture those friendships throughout the year, because we cannot do it alone, you are all needed! Pictured: George Washington...
Divider

FDA files lawsuits to stop unapproved stem cell therapies

Wednesday, May 16, 2018
The Food and Drug Administration (FDA) is seeking court orders to stop several institutions and doctors from using unapproved stem cell treatments and therapies on their patients which, in some cases, have caused serious harm. The FDA filed two...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive